Malignant cells derived from 3T3 fibroblast feeder layer in cell culture for nasopharyngeal carcinoma

Experimental Cell Research

Volumn 322, Issue 1, 2014, Pages 193-201

  Yu, Fenggang ^a   Hsieh, Wen son ^b   Petersson, Fredrik ^a   Yang, Henry ^b   Li, Yingying ^a   Li, Chunwei ^a   Low, Soon Wah ^b   Liu, Jing ^a   Yan, Yan ^a   Wang, De Yun ^a   Loh, Kwok Seng ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

3T3 cells; Cell contact; Feeder layer; Nasopharyngeal carcinoma; Transform

Indexed keywords

ADULT; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL CULTURE; CELL GROWTH; CELL SUBPOPULATION; CLINICAL ARTICLE; FEEDER CELL; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MALIGNANT TRANSFORMATION; MIDDLE AGED; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; SARCOMA; TUMOR XENOGRAFT;

3T3 CELLS; CELL CONTACT; FEEDER LAYER; NASOPHARYNGEAL CARCINOMA; TRANSFORM;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COCULTURE TECHNIQUES; FEEDER CELLS; FEMALE; FIBROBLASTS; HUMANS; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NIH 3T3 CELLS; PRIMARY CELL CULTURE; TUMOR CELLS, CULTURED;

EID: 84893816110     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.12.015     Document Type: Article

References (26)

1. Al-Nedawi K., Meehan B., Rak J. Microvesicles: messengers and mediators of tumor progression. Cell Cycle 2009, 8(13):2014-2018.
2. Schorey J.S., Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic 2008, 9(6):871-881.
3. Yang C., Robbins P.D. The roles of tumor-derived exosomes in cancer pathogenesis. Clin. Dev. Immunol. 2011, 2011:1-11.
4. Taylor D.D., Gercel-Taylor C. Exosomes/Microvesicles: Mediators of Cancer-Associated Immunosuppressive Microenvironments 2011, Springer Berlin Heidelberg, pp. 441-454.
5. D'Souza-Schorey C., Clancy J.W. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 2012, 26(12):1287-1299.
6. Wei W.I., J.S.T.Sham Nasopharyngeal carcinoma. Lancet 2005, 365(9476):2041-2054.
7. Yu F., Sim A.C.N., Li C., Li Y., Zhao X., Wang D.Y., Loh K.S. Identification of a subpopulation of nasopharyngeal carcinoma cells with cancer stem-like cell properties by high aldehyde dehydrogenase activity. Laryngoscope 2013, 123:1903-1911.
8. The AGT cytogenetics laboratory manual 1997, Lippincott-Raven, Philadelphia, (666 p). 3rd ed. M.J. Barch, T. Knutsen, J.L. Spurbeck (Eds.).
9. Chua S.-W., Vijayakumar P., Nissom P.M., Yam C.-Y., Wong V.V., Yang H. A novel normalization method for effective removal of systematic variation in microarray data. Nucleic Acids Res. 2006, 34(5):e38.
10. Duesberg P., Rasnick D. Aneuploidy, the somatic mutation that makes cancer a species of its own. Cell Motil. Cytoskeleton 2000, 47(2):81-107.
11. Thompson M.P., Kurzrock R. Epstein-Barr virus and cancer. Clin. Cancer Res. 2004, 10(3):803-821.
12. Yancopoulos G.D., Nisen P.D., Tesfaye A., Kohl N.E., Goldfarb M.P., Alt F.W. N-myc can cooperate with ras to transform normal cells in culture. Proc. Natl. Acad. Sci. 1985, 82:5455-5459.
13. Land H., Chen A., Morgenstern J., Parada L., Weinberg R. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol. Cell. Biol. 1986, 6:1917-1925.
14. Frank D.A. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett. 2007, 251:199-210.
15. Cohen K.J., Hanna J.S., Prescott J.E., Dang C.V. Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity. Mol. Cell. Biol. 1996, 16:5527-5535.
16. Aaronson S.A., Jainchill J.L., Todaro G.J. Murine sarcoma virus transformation of BALB/3T3 cells: lack of dependence on murine leukemia virus. Proc. Natl. Acad. Sci. 1970, 66(4):1236.
17. Meckes D.G., Shair K.H.Y., Marquitz A.R., Kung C.P., Edwards R.H., Raab-Traub N. Human tumor virus utilizes exosomes for intercellular communication. Proc. Natl. Acad. Sci. 2010, 107(47):20370-20375.
18. Imai S., Nishikawa J., Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 1998, 72(5):4371.
19. Joshi D., Quadri M., Gangane N., Joshi R. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One 2009, 4(12):e8180.
20. Takeuchi H., Kobayashi R., Hasegawa M., Hirai K. Detection of latent Epstein-Barr virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR. Arch. Virol. 1997, 142(9):1743-1756.
21. Teramoto N., Maeda A., Kobayashi K., et al. Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity. Lab. Investig. 2000, 80(3):303-312.
22. Duesberg P., Fabarius A., Hehlmann R. Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells. IUBMB Life 2004, 56(2):65-81.
23. Venugopal C., Wang X.S., Manoranjan B., et al. GBM secretome induces transient transformation of human neural precursor cells. J. Neuro-Oncol. 2012, 109(3):457-466.
24. Hahn W.C., Weinberg R.A. Rules for making human tumor cells. N. Engl. J. Med. 2002, 347(20):1593-1603.
25. Skog J., Würdinger T., Van Rijn S., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10(12):1470-1476.
26. Antonyak M.A., Li B., Boroughs L.K., et al. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc. Natl. Acad. Sci. 2011, 108(12):4852-4857.